Page last updated: 2024-08-23

balsalazide and fulvestrant

balsalazide has been researched along with fulvestrant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bracher, F; Dietschreit, JCB; Ghazy, E; Glas, C; Jung, M; Ochsenfeld, C; Sippl, W; Urban, L; Wössner, N1

Reviews

1 review(s) available for balsalazide and fulvestrant

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for balsalazide and fulvestrant

ArticleYear
Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations.
    European journal of medicinal chemistry, 2020, Nov-15, Volume: 206

    Topics: Drug Design; Histone Deacetylase Inhibitors; Mesalamine; Molecular Docking Simulation; Phenylhydrazines; Protein Conformation; Salicylic Acid; Sirtuins; Structure-Activity Relationship

2020
chemdatabank.com